DEL ZINGARO, Michele
 Distribuzione geografica
Continente #
EU - Europa 16.556
NA - Nord America 9.612
AS - Asia 5.745
SA - Sud America 1.046
Continente sconosciuto - Info sul continente non disponibili 468
AF - Africa 181
OC - Oceania 7
Totale 33.615
Nazione #
IT - Italia 10.063
US - Stati Uniti d'America 9.368
SG - Singapore 2.520
UA - Ucraina 1.429
IE - Irlanda 974
SE - Svezia 898
RU - Federazione Russa 841
BR - Brasile 807
CN - Cina 789
HK - Hong Kong 694
VN - Vietnam 614
FR - Francia 508
DE - Germania 472
FI - Finlandia 350
KR - Corea 297
NL - Olanda 285
GB - Regno Unito 271
IN - India 149
BD - Bangladesh 147
CA - Canada 127
TR - Turchia 125
CH - Svizzera 90
AR - Argentina 87
PL - Polonia 86
BE - Belgio 60
PK - Pakistan 59
MA - Marocco 58
MX - Messico 57
CO - Colombia 53
IQ - Iraq 52
ES - Italia 47
ID - Indonesia 40
ZA - Sudafrica 38
UZ - Uzbekistan 36
JP - Giappone 35
RO - Romania 35
EC - Ecuador 32
AT - Austria 29
SA - Arabia Saudita 27
LB - Libano 20
MY - Malesia 20
CZ - Repubblica Ceca 19
TN - Tunisia 19
EG - Egitto 18
LT - Lituania 18
VE - Venezuela 18
EU - Europa 16
PH - Filippine 15
CR - Costa Rica 13
CL - Cile 12
NP - Nepal 12
IR - Iran 11
UY - Uruguay 11
AE - Emirati Arabi Uniti 10
GR - Grecia 10
PY - Paraguay 10
BG - Bulgaria 9
SM - San Marino 9
AL - Albania 8
BO - Bolivia 8
DZ - Algeria 8
HU - Ungheria 8
IL - Israele 8
JM - Giamaica 8
PT - Portogallo 7
AU - Australia 6
DO - Repubblica Dominicana 6
HN - Honduras 6
JO - Giordania 6
KE - Kenya 6
KZ - Kazakistan 6
SK - Slovacchia (Repubblica Slovacca) 6
TH - Thailandia 6
KG - Kirghizistan 5
OM - Oman 5
PE - Perù 5
PS - Palestinian Territory 5
AZ - Azerbaigian 4
CI - Costa d'Avorio 4
EE - Estonia 4
ET - Etiopia 4
GE - Georgia 4
GT - Guatemala 4
NI - Nicaragua 4
TT - Trinidad e Tobago 4
DK - Danimarca 3
GY - Guiana 3
HR - Croazia 3
KH - Cambogia 3
LY - Libia 3
PA - Panama 3
PR - Porto Rico 3
RS - Serbia 3
SN - Senegal 3
TW - Taiwan 3
AF - Afghanistan, Repubblica islamica di 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BH - Bahrain 2
Totale 33.114
Città #
Singapore 1.733
Chandler 1.352
Milan 1.159
Dublin 966
Jacksonville 694
Hong Kong 687
San Jose 633
San Mateo 595
Rome 576
Ashburn 556
Boardman 385
Santa Clara 319
Dong Ket 312
Seoul 297
Florence 281
Moscow 257
Perugia 257
Turin 256
Medford 251
Princeton 248
Lauterbourg 211
Wilmington 193
Naples 181
Ann Arbor 171
Des Moines 158
Beijing 153
Andover 144
Los Angeles 136
New York 131
Munich 125
Piscataway 124
Altamura 117
Ho Chi Minh City 107
Lawrence 89
Bologna 87
Genoa 84
Shanghai 77
Helsinki 76
Saint Petersburg 71
The Dalles 67
Brescia 66
Hanoi 62
Izmir 62
São Paulo 62
Redwood City 60
Orem 59
Verona 59
Brussels 56
Dallas 56
Palermo 51
Turku 47
Norwalk 44
Ottawa 43
Pescara 43
Bari 42
Woodbridge 42
Chicago 41
Bergamo 40
Torino 40
Ouezzane 38
Chennai 37
Napoli 36
Warsaw 36
Catania 35
Frankfurt am Main 35
Phoenix 35
Brooklyn 34
Montreal 34
Como 33
Council Bluffs 33
Stockholm 32
Tokyo 32
Monza 31
Redmond 30
Padova 28
Atlanta 27
Cagliari 27
Rio de Janeiro 27
Baghdad 26
Falls Church 26
Buffalo 25
Columbus 25
Parma 25
Houston 24
London 24
Tashkent 24
Johannesburg 23
Paris 23
Mumbai 22
Philadelphia 22
Scandiano 22
Belo Horizonte 21
Denver 21
Modena 21
Lucca 20
Manchester 20
Amsterdam 19
Bucharest 19
Caserta 19
Livorno 19
Totale 16.401
Nome #
Il ruolo della TURB II-Look nei tumori superficiali della vescica: revisione sistematica della letteratura e meta-analisi 7.853
BCG vs Gemcitabina per la terapia endovescicale del carcinoma uroteliale ad alto rischio. Studio prospettico randomizzato. 1.788
Ruolo della colposospensione sec.Burch associata a ricostruzione integrale per via addominale in pazienti continenti e incontinenti affette da prolasso urogenitale avanzato. Rivalutazione a lungo termine di 2 studi clinici randomizzati 429
1 hour pad test ha un basso valore predittivo nella diagnosi dell’incontinenza urinaria femminile 419
Ruolo dell’ecografia nella valutazione delle complicanze della chirurgia pelvica con impiego di protesi 277
DIAGNOSI ECOGRAFICA DI DEFICIT SFINTERICO URETRALE NELLA DONNA 267
La correzione del prolasso urogenitale mediante la colposacropessia e la isterocolposacropessia 247
1-hour pad test has low predictive value in the diagnosis of women with urinary incontinence 243
Abdominal integral pelvic reconstruction plus or minus Burch colposuspension in the treatment of severe uro-genital prolapse associated to urinary incontinence. A RCT with a mid-term follow up 180
Abdominal surgery for uterovaginal prolapse: sacropexy vs hysterocolposacropexy 173
Bacillus Calmette-Guérin versus Gemcitabine for intravesical therapy in high-risk superficial bladder cancer: a randomised prospective study 170
SLING MEDIOURETRALE RETROPUBICA E TRANSOTTURATORIA A CONFRONTO NELLE PAZIENTI CON INCONTINENZA URINARIA MISTA NON RESPONSIVA A TERAPIA CONSERVATIVA 170
Renal Artery Embolization Before Radical Nephrectomy for Complex Renal Tumour: Which are the True Advantages? 151
Performance of incontinence impact questionnaire (IIQ) in italian population according to educational status 145
Abdominal pelvic floor reconstruction with uterus preservation 142
A personal surgical experience with orthotopic ileal neo-bladder reconstruction: long term functional results 140
Holmium:YAG Laser for the Treatment of Genital and urethral Warts: Multicentre Prospective Evaluation of Safety and Efficacy 138
Effects of Botulinum-A toxin intravesical injections on bladder hypersensitive disorders: a pilot study 133
Prulifloxacin vs Phosphomycin: Prophylaxis in patients with recurrent UTI. Preliminary results of a randomized multi-centre study 131
Is surgical outcome at risk during post-graduated educational courses for stress urinary incontinence (SUI) and pelvic organ prolapse (POP) repair? A case control study 129
Fournier's gangrene secondary to locally advanced prostate cancer: case report and review of the Literature 129
Long-term outcome of anti-incontinence procedure during Pelvic Organ Prolapse repair in patients with or without urinary incontinence: results from two randomized surgical trials 128
A Camey II Modified Neobladder: Long-Term Complications And Functional Results. 128
Risultati chirurgici nelle donne in età avanzata 127
Colovesical fistula: review on conservative management, surgical techniques and minimally invasive approaches 127
Safety and efficacy of a modified technique of holmium laser enucleation of the prostate (Holep) for benign prostatic hyperplasia 127
Influence of COVID-19 pandemic on stress levels of urologic patients 125
Diagnostic performance of the Bladder EpiCheck methylation test and photodynamic diagnosis-guided cystoscopy in the surveillance of high-risk non-muscle invasive bladder cancer: A single centre, prospective, blinded clinical trial 125
Comparing PUMA with other advanced urodynamic methods in the diagnosis of bladder outlet obstruction in men with benign prostatic hypertrophy 124
Anastomosi microchirurgiche e studio eco-color-Doppler 124
Advanced Urodynamic methods in the diagnosis of bladder outlet obstruction in females 123
Il Q-tip test vs ecografia nella diagnosi di ipermobilità uretrale: nostra esperienza 123
Leiomioma mixoide vaginale parauretrale 122
Fournier's Gangrene and Intravenous Drug Abuse: an Unusual Case Report and Review of The Literature 122
Test-retest of Valsalva leak point pressure 119
Valsalva Leak Point pressure e successo della uretropessi retropubica nelle pazienti affette da severo prolasso urogenitale. Dati preliminari 119
Determinazione dei livelli vescicali tissutali di isoprostano 8-epi-PGF2 alfa in pazienti con disfunzioni vescico-sfinteriche ad elevato stress ossidativo 119
Affidabilità dell'ecografia nella diagnosi dell'ipermobilità uretrale: dati preliminari 119
Uterus preservation vs hysterectomy during sacropexy 119
La colposospensione associata a Ricostruzione integrale del pavimento pelvico. 118
Body mass Index and urinary symptoms in women 116
Management of healing abnormalities after abdominal pelvic organ prolapse repair 116
Botulinum a toxin intravesical injections for painful bladder syndrome: impact upon pain, psychological functioning and quality of life 116
New evolution of robotic radical prostatectomy: A single center experience with PERUSIA technique 116
Bladder tissue levels of nerve growth factor in patients with benign prostatic hyperplasia and detrusor overactivity treated with tamsulosin. 115
Prospettiva di impiego della RMN nel follow-up dell’operato di amputazione addomino-perineale per carcinomale rettale 115
POLYVINYLIDENFLUORID (PVDF) AND POLYPROPYLENE MESH FOR SACROCOLPOPEXY: A COMPARATIVE STUDY 115
Diagnosi ecografica di iperattività detrusoriale: nostra esperienza 114
Sacropexy with uterine conservation: results after 5 years 114
.“Semeiotica urologica” Manuale di Chirurgia Monduzzi Editore 113
Long-Term follow-up uterus sparing surgery for pelvic organ prolapse (POP) 113
Evaluation of Surgical Site Infection in Mini-invasive Urological Surgery 112
Early recovery of pre-RARP latency time in uroflow stop test with EMG may predict early erectile function restoration 112
Ruolo dell’ESWL nella terapia della litiasi complessaCongresso Nazionale SIU 111
Disobstruction after RARP in low-risk prostate cancer: a case-control study 111
A PROSPECTIVE RANDOMIZED TRIAL: ABDOMINAL VS LAPAROSCOPIC SACROPEXY FOR ADVANCED PELVIC ORGAN PROLAPSE 110
Bladder and urethral sphincter function after radical retropubic prostectomy: 3 years follow up. 109
Botulinum-A toxin injections into the detrusor muscle reduce nerve growth factor bladder tissue levels in patients affected by neurogenic detrusor overactivity. 109
Iniezione intravescicale di tossina botulinica A nel trattamento della vescica ipersensibile 109
Bladder outlet obstruction in men with benign prostatic hypertrophy 109
UROLOGIC LATENCY TIME (ULT) DURING UROFLOW STOP TEST WITH ELECTROMYOGRAPHY: A POST-RARP CONTINENCE DETECTOR 109
Is Valsalva Leak point pressure a reliable test? 107
VALUTAZIONE ECOGRAFICA DELLE PAZIENTI SOTTOPOSTE AD INTERVENTO DI CORREZZIONE DELLA STATICA PELVICA CON IMPIEGO DI PROTESI 107
ESWL in Renal Stone Clearance from Calyxes 107
Somministrazione intradetrusoriale di tossina botulinica A in pazienti con iperattività detrusoriale e vescica iperattiva dovute a M. di Parkinson ed Atrofia Multisistemica 107
La colposospensione associata a ricostruzione integrale del pavimento pelvico 106
Affidabilità dell’ecografia nella diagnosi dell’ipermobilità uretrale: dati preliminari 106
Bcg vs. Gemcitabina per la terapia endovescicale del carcinoma uroteliale ad alto rischio: Studio prospettico randomizzato 106
A Camey II Modified Neobladder: Long-Term Complications And Functional Results. 105
Robotic treatment of oligometastatic kidney tumor with synchronous pancreatic metastasis: Case report and review of the literature 105
Ruolo della re-turb nei tumori vesciali superficiali ad altro rischio di progressione e recidiva. 104
Bladder tissue levels of NGF in SCI patients with detrusor overactivity before and after botulinum-A toxin injections into the detrusor muscle 104
Chirurgia del prolasso con preservazione dell’utero: risultati a lungo termine 104
Role of miRNAs in prostate cancer: Do we really know everything? 104
BOTULINUM-A TOXIN INJECTIONS INTO THE DETRUSOR MUSCLE REDUCE NERVE GROWTH FACTOR BLADDER TISSUE LEVELS IN P A TIENTS AFFECTED BY NEUROGENIC DETRUSOR OVER- ACTIVITY 103
Il q-tip test nella diagnosi di ipermobilità uretrale 103
Validation in an Independent Cohort of MiR-122, MiR-1271, and MiR-15b as Urinary Biomarkers for the Potential Early Diagnosis of Clear Cell Renal Cell Carcinoma 102
Preservazione dell'utero o isterectomia negli interventi di sacropessia per prolasso uterovaginale: due tecniche a confronto 101
Surgical outcome during post-graduated educational courses for stress urinary incontinence (SUI) and pelvic organ prolapse (POP) repair: case control study 101
Female sexual function evaluation in patients who underwent integral pelvic floor reconstructive surgery 101
Botulinum Toxin A for Overactive Bladder and Detrusor Muscle Overactivity in Patients With Parkinson's Disease and Multiple System Atrophy 101
Enhanced patient recovery with early extensive surgical deb-ridement in Fournier's Gangrene: evaluation of perioperative outcomes in a multicentric experience 100
Burch colposuspension does not provide any additional benefit to pelvic organ prolapse repair in patients with urinary incontinence: A randomized surgical trial 100
Traumi della milza : nostra esperienza 99
Echo-color doppler in the diagnosis of vascular abnormalities associated with ureteropelvic junction obstruction 98
Profilassi con Plurifloxacina vs Fosfomicina in pawienti affette da cistiti ricorrenti. Risultati preliminari di uno studio randomizzato 98
Preoperative urinary incontinence is the main risk factor for post-operative incontinence in women who underwent POP (Pelvic Organ Prolapse) repair 98
ABDOMINAL VS LAPAROSCOPIC SACROCOLPOPEXY: A RANDOMIZED CONTROLLED TRIAL 98
Relationships between voiding dysfunction and peripheral neuropathy in asymptomatic patients affected by diabetes mellitus type I: preliminary results. 97
The management of pelvic organ prolapse. A review 97
Nerve Growth Factor bladder tissue levels in patients with benign prostatic hyperplasia and detrusor overactivity treated with tamsulosin. 97
ESWL e Anestesia locale con EMLA:risultati 97
Trattamento endovescicale adiuvante del TCC superficiale ad alto rischio con mitomicina elettroindotta vs BCG. 97
Isterocolposacropessia:confronto tra videolaparoscopia e chirurgia open 97
Pre and post-operative urodynamic patterns and continence in patients undergoing bladder-neck- sparing radical retro-pubic prostatectomy (RRP) 97
Ricostruzione integrale del pavimento pelvico 96
Valutazione ecografica delle pazienti sottoposte ad intervento di correzione della statica pelvica con impiego di protesi 96
Mini-invasive techniques for the treatment of female stress urinary incontinence 96
Botulinum A toxin in the treatment of neurogenic detrusor overactivity: a consolidated field of application 96
Recurvatum congeniti ed acquisiti del pene 95
Totale 22.089
Categoria #
all - tutte 112.945
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 112.945


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.381 0 0 129 237 141 68 84 640 81 93 393 515
2022/20235.306 409 592 241 358 397 583 173 405 1.463 139 329 217
2023/20243.015 228 287 193 202 134 105 438 264 303 175 370 316
2024/20255.201 218 493 260 287 652 269 269 445 813 372 662 461
2025/20268.251 655 617 495 1.020 933 666 1.179 447 910 800 297 232
2026/2027918 291 319 308 0 0 0 0 0 0 0 0 0
Totale 33.615